Holds one active US DMF and one valid CEP for flecainide, filing since 2021. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF and one valid CEP for flecainide, filing since 2019. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one valid CEP for flecainide, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.
Holds one active US DMF and one valid CEP for flecainide, filing since 2017. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for flecainide, filing since 2006. Its GMP is recognised in 5 markets.
Holds 2 active US DMFs for flecainide, filing since 1994. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for flecainide, filing since 2000.
Holds one active US DMF for flecainide, filing since 2022.
Holds one valid CEP for flecainide, filing since 2023. Its GMP is recognised in 2 markets.
Holds one valid CEP for flecainide, filing since 2024. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free